One Disease, Two Lives: Exploring the Treatment of Breast Cancer During Pregnancy

2.50
Hdl Handle:
http://hdl.handle.net/10755/164774
Category:
Abstract
Type:
Presentation
Title:
One Disease, Two Lives: Exploring the Treatment of Breast Cancer During Pregnancy
Author(s):
Meyer, Lara; Visco, Alexa; Allen, Fletcher; Brown, Carlton
Author Details:
Lara Meyer, BSN, RN, RN2, University of Washington Medical Center, Seattle, Washington, USA, email: laram819@aol.com; Alexa Visco, BSN, RN, Fletcher Allen Healthcare Medical Center, Burlington, Vermont; Carlton Brown, PhD, RN, AOCN, U. of Delaware, Newark, Delaware
Abstract:
Research Study: As women in the United States are continuing to delay childbirth and because the risk of breast cancer increases with age, it can be hypothesized that the incidence of breast cancer during pregnancy will increase. Historically, the two spheres of clinical care (labor and delivery and oncology) rarely overlapped. Recent case studies suggest that the administration of chemotherapeutic agents during the second and third trimester may be safe to both the mother and fetus. Therefore, this presentation aims to discuss the current trends in breast cancer and pregnancy and the associated nursing implications. The amount of evidenced-based knowledge surrounding the treatment of breast cancer during pregnancy is extremely limited. The goal of the presentation is to focus on three specific case studies of patients with breast cancer who underwent treatment during pregnancy, discussing outcomes of mothers and infants who received chemotherapy in utero and explore associated nursing implications. Statistical and case study analysis are used to identify hypotheses, risk factors and outcomes of pregnant women with breast cancer, highlighting the role of the nurse throughout each stage of the treatment process. Three case studies are analyzed and presented in the absence of randomized clinical trials to investigate the safe use of chemotherapeutic agents during pregnancy. The outcomes of mother and baby are addressed with regards to treatment and gestational age. Maternal and neonatal follow up are used to conclude long term effects of treatment. In reviewing the selected case reports, patients were most commonly diagnosed at advanced stages of cancer making the dilemma between aggressive chemotherapy and fetal safety inevitable. The outcomes of these women and their treatments are not conclusive in diagnosing and determining treatment for pregnant women with breast cancer, but rather bring attention to the possibilities of life saving treatments that may have been considered contraindicated in the past. Caring for such patients requires the nurse to be proficient in the most current research and evidenced based treatments, as well as having the knowledge and ability to provide emotional and psychological support for these patients and their families.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2009
Conference Name:
34th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
San Antonio, Texas, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleOne Disease, Two Lives: Exploring the Treatment of Breast Cancer During Pregnancyen_GB
dc.contributor.authorMeyer, Laraen_US
dc.contributor.authorVisco, Alexaen_US
dc.contributor.authorAllen, Fletcheren_US
dc.contributor.authorBrown, Carltonen_US
dc.author.detailsLara Meyer, BSN, RN, RN2, University of Washington Medical Center, Seattle, Washington, USA, email: laram819@aol.com; Alexa Visco, BSN, RN, Fletcher Allen Healthcare Medical Center, Burlington, Vermont; Carlton Brown, PhD, RN, AOCN, U. of Delaware, Newark, Delawareen_US
dc.identifier.urihttp://hdl.handle.net/10755/164774-
dc.description.abstractResearch Study: As women in the United States are continuing to delay childbirth and because the risk of breast cancer increases with age, it can be hypothesized that the incidence of breast cancer during pregnancy will increase. Historically, the two spheres of clinical care (labor and delivery and oncology) rarely overlapped. Recent case studies suggest that the administration of chemotherapeutic agents during the second and third trimester may be safe to both the mother and fetus. Therefore, this presentation aims to discuss the current trends in breast cancer and pregnancy and the associated nursing implications. The amount of evidenced-based knowledge surrounding the treatment of breast cancer during pregnancy is extremely limited. The goal of the presentation is to focus on three specific case studies of patients with breast cancer who underwent treatment during pregnancy, discussing outcomes of mothers and infants who received chemotherapy in utero and explore associated nursing implications. Statistical and case study analysis are used to identify hypotheses, risk factors and outcomes of pregnant women with breast cancer, highlighting the role of the nurse throughout each stage of the treatment process. Three case studies are analyzed and presented in the absence of randomized clinical trials to investigate the safe use of chemotherapeutic agents during pregnancy. The outcomes of mother and baby are addressed with regards to treatment and gestational age. Maternal and neonatal follow up are used to conclude long term effects of treatment. In reviewing the selected case reports, patients were most commonly diagnosed at advanced stages of cancer making the dilemma between aggressive chemotherapy and fetal safety inevitable. The outcomes of these women and their treatments are not conclusive in diagnosing and determining treatment for pregnant women with breast cancer, but rather bring attention to the possibilities of life saving treatments that may have been considered contraindicated in the past. Caring for such patients requires the nurse to be proficient in the most current research and evidenced based treatments, as well as having the knowledge and ability to provide emotional and psychological support for these patients and their families.en_GB
dc.date.available2011-10-27T12:06:45Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:06:45Z-
dc.conference.date2009en_US
dc.conference.name34th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationSan Antonio, Texas, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.